Published in JAMA Dermatology
Importance Treatment of erythema and flushing in rosacea is challenging. Calcitonin gene-related peptide (CGRP) has been associated with the pathogenesis of rosacea, raising the possibility that inhibition of the CGRP pathway might improve certain features of the disease. Objective To examine the effectiveness, tolerability, and safety of erenumab,...
Published in JAMA Dermatology
This cohort study assesses the incidence rate of second primary invasive melanoma at least 30 days after the first based on data from deidentified records of all invasive melanomas diagnosed in 2008 to 2020, obtained from the Cancer Registry of Norway.
Published in JAMA Dermatology
Importance The development of artificial intelligence (AI)–based melanoma classifiers typically calls for large, centralized datasets, requiring hospitals to give away their patient data, which raises serious privacy concerns. To address this concern, decentralized federated learning has been proposed, where classifier development is distributed ac...
Published in JAMA dermatology
Vitiligo is a multifactorial, depigmenting skin disorder characterized by selective loss of melanocytes. Large-scale studies are lacking to determine the risk of vitiligo in transplant recipients with graft-vs-host disease (GVHD). To investigate the incidence rates and risk of vitiligo in patients who had received solid organ transplant (SOT) or he...
Published in JAMA Dermatology
Importance Despite the US Food and Drug Administration’s approval of adalimumab for the treatment of hidradenitis suppurativa (HS), prescription rates remain low, indicating a critical gap between evidence-based guidelines and clinical practice. Understanding the medical decision-making process that these patients use when considering biologic agen...
Published in JAMA Dermatology
This cohort study examines the incidence, prevalence, and risk of alopecia areata after COVID-19.
Published in JAMA Dermatology
Importance Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer. Of the patients who develop MCC annually, only 4% are younger than 50 years. Objective To identify genetic risk factors for early-onset MCC via genomic sequencing. Design, Setting, and Participants The study represents a multicenter collaboration between the Na...
Published in JAMA Dermatology
This cohort study characterizes the presentation, causes, treatment, and disease course of erythema nodosum, as well as identifies associations with chronicity and recurrence.
Published in JAMA Dermatology
Importance While acne is common in transgender and gender-diverse people and is associated with gender-affirming hormone therapy, little research has examined these factors and their impact in gender minority groups. Objective To examine the lived experiences of acne and acne treatment in transgender and gender-diverse participants. Design, Setting...
Published in JAMA dermatology
Treatment satisfaction is important to achieving therapeutic success in patients with inflammatory dermatological diseases, such as acne. To evaluate the structural validity, internal consistency, and construct validity of the DermSat-7, a questionnaire-based measure of treatment satisfaction, in patients with acne seen in routine clinical practice...
